Effect of a new synbiotic infant formula on the gut microbiota of infants delivered by Caesarian Section.
Completed
- Conditions
- Healthy term born infants, born to healthy pregnant women
- Registration Number
- NL-OMON23445
- Lead Sponsor
- Danone Research
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 168
Inclusion Criteria
1. Healthy term born infants, born to healthy pregnant women;
2. Parents are willing and able to comply with the protocol;
Exclusion Criteria
For the mothers:
1. Fever ≥ 38.5° during the last week before birth;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of the two test products compared to the effect of the control product in infants delivered by Caesarean section on the total bifidobacteria count of the gut microbiota.
- Secondary Outcome Measures
Name Time Method The effect of the two test products compared to the effect of the control product in infants delivered by Caesarean section on the bifidobacteria distribution, the composition of other members of the gut microbiota and metabolic activity. <br /><br>For the reference group bifidobacteria distribution, the composition of other members of the gut microbiota and metabolic activity will be measured in.